_id
691311faccc777a4e85d7f0e
Ticker
LYPHF
Name
Luye Pharma Group Ltd
Exchange
PINK
Address
No. 15 Chuang Ye Road, Yantai, China, 264003
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.luye.cn
Description
Luye Pharma Group Ltd., together with its subsidiaries, develops, produces, markets, and sells pharmaceutical products in the People's Republic of China, the United States, Europe, and internationally. The company offers Lipusu for ovarian cancer and carcinoma of ovary; CMNa, a chemical sensitizer for cancer radiotherapy; Boyounuo, an injection for the treatment of various types of cancers; and Xuezhikang, a lipid-regulating drug for the treatment of hypercholesterolaemia. It also provides Maitongna for cerebral edema swelling by trauma or surgery, and for venous reflux disorders; Beixi, an acarbose capsule for Type 2 diabetes; and Seroquel, Seroquel XR, Erzofri, Rivastigmine Multi-Day Transdermal Patch, and Rivastigmine. In addition, the company offers Rykindo, an injection for the treatment of schizophrenia; and Lutingnuo, a glutathione injection for toxicity and injuries caused by ionizing radiation. Further, it offers Oukai; Meibirui; Jinyouping; and other products. The company distributes and sells pharmaceutical drugs; research and development of antibody drugs; and manufactures and sells biopharmaceutical products. Luye Pharma Group Ltd. was founded in 1994 and is headquartered in Yantai, the People's Republic of China.
Last Close
0.3746
Volume
400
Current Price
0.3776
Change
-0.0157
Last Updated
2026-01-05T10:01:37.579Z
Image
-
Ipo Date
-
Market Cap
1496465536
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
3181110000
Cost Of Revenue
1023501000
Gross Profit
2157609000
Operating Expenses
1527719000
Operating Income
629890000
Interest Expense
-
Pretax Income
457640000
Net Income
312886000
Eps
0.08317740432226352
Dividends Per Share
-
Shares Outstanding
3994515953
Income Tax Expense
100257000
EBITDA
1003569000
Operating Margin
19.800949982867618
Total Other Income Expense Net
-172250000
Cash
6936206000
Short Term Investments
1896839000
Receivables
3520504000
Inventories
871650000
Total Current Assets
15687178000
Property Plant Equipment
5924639000
Total Assets
32031465000
Payables
663482000
Short Term Debt
8721451000
Long Term Debt
3111869000
Total Liabilities
15488850000
Equity
14692527000
Bs_currency_symbol
CNY
Depreciation
408138000
Change In Working Capital
888061000
Cash From Operations
1784352000
Capital Expenditures
0
Cash From Investing
-267365000
Cash From Financing
583809000
Net Change In Cash
6936206000
Cf_currency_symbol
-
PE
18.7315
PB
0.09667546194040004
ROE
2.1295587886277154
ROA
0.9768082727405694
FCF
1784352000
Fcf Percent
0.5609211878872469
Piotroski FScore
4
Health Score
61
Deep Value Investing Score
7.5
Defensive Investing Score
6
Dividend Investing Score
3
Economic Moat Investing Score
6.3
Garp Investing Score
6
Growth Investing Score
5.5
Momentum Investing Score
6.5
Net Net Investing Score
4
Quality Investing Score
4.5
Value Investing Score
6
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
3181110000
Quarters > 0 > income Statement > cost Of Revenue
1023501000
Quarters > 0 > income Statement > gross Profit
2157609000
Quarters > 0 > income Statement > operating Expenses
1527719000
Quarters > 0 > income Statement > operating Income
629890000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
457640000
Quarters > 0 > income Statement > net Income
312886000
Quarters > 0 > income Statement > eps
0.08317740432226352
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
3761670643
Quarters > 0 > income Statement > income Tax Expense
100257000
Quarters > 0 > income Statement > EBITDA
1003569000
Quarters > 0 > income Statement > operating Margin
19.800949982867618
Quarters > 0 > income Statement > total Other Income Expense Net
-172250000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
6936206000
Quarters > 0 > balance Sheet > short Term Investments
1896839000
Quarters > 0 > balance Sheet > receivables
3520504000
Quarters > 0 > balance Sheet > inventories
871650000
Quarters > 0 > balance Sheet > total Current Assets
15687178000
Quarters > 0 > balance Sheet > property Plant Equipment
5924639000
Quarters > 0 > balance Sheet > total Assets
32031465000
Quarters > 0 > balance Sheet > payables
663482000
Quarters > 0 > balance Sheet > short Term Debt
8721451000
Quarters > 0 > balance Sheet > long Term Debt
3111869000
Quarters > 0 > balance Sheet > total Liabilities
15488850000
Quarters > 0 > balance Sheet > equity
14692527000
Quarters > 0 > balance Sheet > currency_symbol
CNY
Quarters > 0 > cash Flow > net Income
312886000
Quarters > 0 > cash Flow > depreciation
408138000
Quarters > 0 > cash Flow > change In Working Capital
888061000
Quarters > 0 > cash Flow > cash From Operations
1784352000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-267365000
Quarters > 0 > cash Flow > cash From Financing
583809000
Quarters > 0 > cash Flow > net Change In Cash
6936206000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.08317740432226352
Quarters > 0 > ratios > PB
0.09667546194040004
Quarters > 0 > ratios > ROE
2.1295587886277154
Quarters > 0 > ratios > ROA
0.9768082727405694
Quarters > 0 > ratios > FCF
1784352000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.5609211878872469
Quarters > 0 > health Score
61
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
2986859000
Quarters > 1 > income Statement > cost Of Revenue
1021182000
Quarters > 1 > income Statement > gross Profit
1965677000
Quarters > 1 > income Statement > operating Expenses
1332259000
Quarters > 1 > income Statement > operating Income
633418000
Quarters > 1 > income Statement > interest Expense
561785000
Quarters > 1 > income Statement > pretax Income
309242000
Quarters > 1 > income Statement > net Income
84050000
Quarters > 1 > income Statement > eps
0.022343795610178303
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
3761670643
Quarters > 1 > income Statement > income Tax Expense
102412000
Quarters > 1 > income Statement > EBITDA
1252206000
Quarters > 1 > income Statement > operating Margin
21.206826301475896
Quarters > 1 > income Statement > total Other Income Expense Net
-324176000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
4937145000
Quarters > 1 > balance Sheet > short Term Investments
1566067000
Quarters > 1 > balance Sheet > receivables
4300696000
Quarters > 1 > balance Sheet > inventories
911893000
Quarters > 1 > balance Sheet > total Current Assets
13308107000
Quarters > 1 > balance Sheet > property Plant Equipment
5890856000
Quarters > 1 > balance Sheet > total Assets
29612200000
Quarters > 1 > balance Sheet > payables
689300000
Quarters > 1 > balance Sheet > short Term Debt
7585074000
Quarters > 1 > balance Sheet > long Term Debt
2693813000
Quarters > 1 > balance Sheet > total Liabilities
13858530000
Quarters > 1 > balance Sheet > equity
14154529000
Quarters > 1 > balance Sheet > currency_symbol
CNY
Quarters > 1 > cash Flow > net Income
451383000
Quarters > 1 > cash Flow > depreciation
442367000
Quarters > 1 > cash Flow > change In Working Capital
-18511000
Quarters > 1 > cash Flow > cash From Operations
562164000
Quarters > 1 > cash Flow > capital Expenditures
1708497000
Quarters > 1 > cash Flow > cash From Investing
-965943000
Quarters > 1 > cash Flow > cash From Financing
1975858000
Quarters > 1 > cash Flow > net Change In Cash
4886807000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.022343795610178303
Quarters > 1 > ratios > PB
0.10034998937773203
Quarters > 1 > ratios > ROE
0.5938028739776505
Quarters > 1 > ratios > ROA
0.2838357163601488
Quarters > 1 > ratios > FCF
-1146333000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
-0.38379213749293156
Quarters > 1 > health Score
47
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
3074582000
Quarters > 2 > income Statement > cost Of Revenue
996032000
Quarters > 2 > income Statement > gross Profit
2078550000
Quarters > 2 > income Statement > operating Expenses
1420913000
Quarters > 2 > income Statement > operating Income
657637000
Quarters > 2 > income Statement > interest Expense
38545955
Quarters > 2 > income Statement > pretax Income
529977000
Quarters > 2 > income Statement > net Income
387836000
Quarters > 2 > income Statement > eps
0.1031020620377051
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3761670643
Quarters > 2 > income Statement > income Tax Expense
91799000
Quarters > 2 > income Statement > EBITDA
939470000
Quarters > 2 > income Statement > operating Margin
21.389476683334514
Quarters > 2 > income Statement > total Other Income Expense Net
-127660000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
3339649000
Quarters > 2 > balance Sheet > short Term Investments
1509000000
Quarters > 2 > balance Sheet > receivables
3508100000
Quarters > 2 > balance Sheet > inventories
815546000
Quarters > 2 > balance Sheet > total Current Assets
12535926000
Quarters > 2 > balance Sheet > property Plant Equipment
5258890000
Quarters > 2 > balance Sheet > total Assets
27198480000
Quarters > 2 > balance Sheet > payables
797008000
Quarters > 2 > balance Sheet > short Term Debt
6669023000
Quarters > 2 > balance Sheet > long Term Debt
2734180000
Quarters > 2 > balance Sheet > total Liabilities
13113827000
Quarters > 2 > balance Sheet > equity
13019403000
Quarters > 2 > balance Sheet > currency_symbol
CNY
Quarters > 2 > cash Flow > net Income
387836000
Quarters > 2 > cash Flow > depreciation
348305000
Quarters > 2 > cash Flow > change In Working Capital
-1215243000
Quarters > 2 > cash Flow > cash From Operations
-394400000
Quarters > 2 > cash Flow > capital Expenditures
99317475
Quarters > 2 > cash Flow > cash From Investing
-505313000
Quarters > 2 > cash Flow > cash From Financing
980399000
Quarters > 2 > cash Flow > net Change In Cash
50338000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.1031020620377051
Quarters > 2 > ratios > PB
0.10909922941910623
Quarters > 2 > ratios > ROE
2.9789077118205802
Quarters > 2 > ratios > ROA
1.4259473323509255
Quarters > 2 > ratios > FCF
-493717475
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.16058035693957748
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
1537291000
Quarters > 3 > income Statement > cost Of Revenue
498016000
Quarters > 3 > income Statement > gross Profit
1039275000
Quarters > 3 > income Statement > operating Expenses
710456500
Quarters > 3 > income Statement > operating Income
328818500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
264988500
Quarters > 3 > income Statement > net Income
193918000
Quarters > 3 > income Statement > eps
0.05155103101885255
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
3761670643
Quarters > 3 > income Statement > income Tax Expense
45899500
Quarters > 3 > income Statement > EBITDA
469735000
Quarters > 3 > income Statement > operating Margin
21.389476683334514
Quarters > 3 > income Statement > total Other Income Expense Net
-63830000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
3339649000
Quarters > 3 > balance Sheet > short Term Investments
1509000000
Quarters > 3 > balance Sheet > receivables
2577607000
Quarters > 3 > balance Sheet > inventories
815546000
Quarters > 3 > balance Sheet > total Current Assets
12535926000
Quarters > 3 > balance Sheet > property Plant Equipment
5258890000
Quarters > 3 > balance Sheet > total Assets
27198480000
Quarters > 3 > balance Sheet > payables
797008000
Quarters > 3 > balance Sheet > short Term Debt
6669023000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
13113827000
Quarters > 3 > balance Sheet > equity
13019403000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
193918000
Quarters > 3 > cash Flow > depreciation
174152500
Quarters > 3 > cash Flow > change In Working Capital
-607621500
Quarters > 3 > cash Flow > cash From Operations
-197200000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
490199500
Quarters > 3 > cash Flow > net Change In Cash
50338000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.05155103101885255
Quarters > 3 > ratios > PB
0.10909922941910623
Quarters > 3 > ratios > ROE
1.4894538559102901
Quarters > 3 > ratios > ROA
0.7129736661754628
Quarters > 3 > ratios > FCF
-197200000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.1282776000119691
Quarters > 3 > health Score
40
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
6061441000
Annuals > 0 > income Statement > cost Of Revenue
2017214000
Annuals > 0 > income Statement > gross Profit
4044227000
Annuals > 0 > income Statement > operating Expenses
2753172000
Annuals > 0 > income Statement > operating Income
1291055000
Annuals > 0 > income Statement > interest Expense
561785000
Annuals > 0 > income Statement > pretax Income
839219000
Annuals > 0 > income Statement > net Income
471886000
Annuals > 0 > income Statement > eps
0.1254458576478834
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
3761670643
Annuals > 0 > income Statement > income Tax Expense
194211000
Annuals > 0 > income Statement > EBITDA
2191676000
Annuals > 0 > income Statement > operating Margin
21.299473178077623
Annuals > 0 > income Statement > total Other Income Expense Net
-451836000
Annuals > 0 > income Statement > currency_symbol
CNY
Annuals > 0 > balance Sheet > cash
4937145000
Annuals > 0 > balance Sheet > short Term Investments
1566067000
Annuals > 0 > balance Sheet > receivables
4300696000
Annuals > 0 > balance Sheet > inventories
911893000
Annuals > 0 > balance Sheet > total Current Assets
13308107000
Annuals > 0 > balance Sheet > property Plant Equipment
5890856000
Annuals > 0 > balance Sheet > total Assets
29612200000
Annuals > 0 > balance Sheet > payables
689300000
Annuals > 0 > balance Sheet > short Term Debt
7585074000
Annuals > 0 > balance Sheet > long Term Debt
2693813000
Annuals > 0 > balance Sheet > total Liabilities
13858530000
Annuals > 0 > balance Sheet > equity
14154529000
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
839219000
Annuals > 0 > cash Flow > depreciation
790672000
Annuals > 0 > cash Flow > change In Working Capital
-1233754000
Annuals > 0 > cash Flow > cash From Operations
167764000
Annuals > 0 > cash Flow > capital Expenditures
1708497000
Annuals > 0 > cash Flow > cash From Investing
-1471256000
Annuals > 0 > cash Flow > cash From Financing
2956257000
Annuals > 0 > cash Flow > net Change In Cash
1698172000
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
0.1254458576478834
Annuals > 0 > ratios > PB
0.09955271721636233
Annuals > 0 > ratios > ROE
3.3338163353934274
Annuals > 0 > ratios > ROA
1.5935526573506866
Annuals > 0 > ratios > FCF
-1540733000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
-0.25418592707575643
Annuals > 0 > health Score
49
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
6143078000
Annuals > 1 > income Statement > cost Of Revenue
1938903000
Annuals > 1 > income Statement > gross Profit
4204175000
Annuals > 1 > income Statement > operating Expenses
3175450000
Annuals > 1 > income Statement > operating Income
1028725000
Annuals > 1 > income Statement > interest Expense
675454000
Annuals > 1 > income Statement > pretax Income
700100000
Annuals > 1 > income Statement > net Income
532605000
Annuals > 1 > income Statement > eps
0.14285224388578127
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
3728362856
Annuals > 1 > income Statement > income Tax Expense
161023000
Annuals > 1 > income Statement > EBITDA
2077405000
Annuals > 1 > income Statement > operating Margin
16.746083966376464
Annuals > 1 > income Statement > total Other Income Expense Net
-328625000
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
3238973000
Annuals > 1 > balance Sheet > short Term Investments
1271695000
Annuals > 1 > balance Sheet > receivables
2587657000
Annuals > 1 > balance Sheet > inventories
827863000
Annuals > 1 > balance Sheet > total Current Assets
10703282000
Annuals > 1 > balance Sheet > property Plant Equipment
5088505000
Annuals > 1 > balance Sheet > total Assets
25490715000
Annuals > 1 > balance Sheet > payables
767187000
Annuals > 1 > balance Sheet > short Term Debt
5195754000
Annuals > 1 > balance Sheet > long Term Debt
3176047000
Annuals > 1 > balance Sheet > total Liabilities
11962221000
Annuals > 1 > balance Sheet > equity
12531185000
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
700100000
Annuals > 1 > cash Flow > depreciation
701851000
Annuals > 1 > cash Flow > change In Working Capital
397988000
Annuals > 1 > cash Flow > cash From Operations
1595487000
Annuals > 1 > cash Flow > capital Expenditures
1165261000
Annuals > 1 > cash Flow > cash From Investing
-1418258000
Annuals > 1 > cash Flow > cash From Financing
841599000
Annuals > 1 > cash Flow > net Change In Cash
915233000
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
0.14285224388578127
Annuals > 1 > ratios > PB
0.11145352381738836
Annuals > 1 > ratios > ROE
4.250236509954965
Annuals > 1 > ratios > ROA
2.0894078490932873
Annuals > 1 > ratios > FCF
430226000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.07003427272126449
Annuals > 1 > health Score
56
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
5981656000
Annuals > 2 > income Statement > cost Of Revenue
1841140000
Annuals > 2 > income Statement > gross Profit
4140516000
Annuals > 2 > income Statement > operating Expenses
3186638000
Annuals > 2 > income Statement > operating Income
1214982000
Annuals > 2 > income Statement > interest Expense
471755000
Annuals > 2 > income Statement > pretax Income
669762000
Annuals > 2 > income Statement > net Income
604807000
Annuals > 2 > income Statement > eps
0.17375253683344882
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
3480852775
Annuals > 2 > income Statement > income Tax Expense
86466000
Annuals > 2 > income Statement > EBITDA
1812830000
Annuals > 2 > income Statement > operating Margin
20.31179994302581
Annuals > 2 > income Statement > total Other Income Expense Net
-210856000
Annuals > 2 > income Statement > currency_symbol
CNY
Annuals > 2 > balance Sheet > cash
2323740000
Annuals > 2 > balance Sheet > short Term Investments
3220524000
Annuals > 2 > balance Sheet > receivables
1783686000
Annuals > 2 > balance Sheet > inventories
772939000
Annuals > 2 > balance Sheet > total Current Assets
10785813000
Annuals > 2 > balance Sheet > property Plant Equipment
4909126000
Annuals > 2 > balance Sheet > total Assets
24249625000
Annuals > 2 > balance Sheet > payables
559944000
Annuals > 2 > balance Sheet > short Term Debt
6839788000
Annuals > 2 > balance Sheet > long Term Debt
2241494000
Annuals > 2 > balance Sheet > total Liabilities
13207903000
Annuals > 2 > balance Sheet > equity
10175954000
Annuals > 2 > balance Sheet > currency_symbol
CNY
Annuals > 2 > cash Flow > net Income
669762000
Annuals > 2 > cash Flow > depreciation
671313000
Annuals > 2 > cash Flow > change In Working Capital
319792000
Annuals > 2 > cash Flow > cash From Operations
1653796000
Annuals > 2 > cash Flow > capital Expenditures
1163659000
Annuals > 2 > cash Flow > cash From Investing
-1658308000
Annuals > 2 > cash Flow > cash From Financing
54148000
Annuals > 2 > cash Flow > net Change In Cash
-114512000
Annuals > 2 > cash Flow > currency_symbol
CNY
Annuals > 2 > ratios > PE
0.17375253683344882
Annuals > 2 > ratios > PB
0.1281381037605909
Annuals > 2 > ratios > ROE
5.9434918829232135
Annuals > 2 > ratios > ROA
2.494088052908035
Annuals > 2 > ratios > FCF
490137000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.08194001794820699
Annuals > 2 > health Score
52
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
5200226000
Annuals > 3 > income Statement > cost Of Revenue
1803486000
Annuals > 3 > income Statement > gross Profit
3396740000
Annuals > 3 > income Statement > operating Expenses
3113934000
Annuals > 3 > income Statement > operating Income
386987000
Annuals > 3 > income Statement > interest Expense
399458000
Annuals > 3 > income Statement > pretax Income
-74557000
Annuals > 3 > income Statement > net Income
-144783000
Annuals > 3 > income Statement > eps
-0.04202173391488288
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
3445431364
Annuals > 3 > income Statement > income Tax Expense
70226000
Annuals > 3 > income Statement > EBITDA
906883000
Annuals > 3 > income Statement > operating Margin
7.441734263087797
Annuals > 3 > income Statement > total Other Income Expense Net
-512517000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2438252000
Annuals > 3 > balance Sheet > short Term Investments
3072057000
Annuals > 3 > balance Sheet > receivables
1765096000
Annuals > 3 > balance Sheet > inventories
746344000
Annuals > 3 > balance Sheet > total Current Assets
10396664000
Annuals > 3 > balance Sheet > property Plant Equipment
4594470000
Annuals > 3 > balance Sheet > total Assets
22582061000
Annuals > 3 > balance Sheet > payables
570890000
Annuals > 3 > balance Sheet > short Term Debt
5263216000
Annuals > 3 > balance Sheet > long Term Debt
4208372000
Annuals > 3 > balance Sheet > total Liabilities
13468158000
Annuals > 3 > balance Sheet > equity
8488123000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-74557000
Annuals > 3 > cash Flow > depreciation
581982000
Annuals > 3 > cash Flow > change In Working Capital
-418082000
Annuals > 3 > cash Flow > cash From Operations
182371000
Annuals > 3 > cash Flow > capital Expenditures
1541595000
Annuals > 3 > cash Flow > cash From Investing
-3436032000
Annuals > 3 > cash Flow > cash From Financing
1878897000
Annuals > 3 > cash Flow > net Change In Cash
-1427133000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.04202173391488288
Annuals > 3 > ratios > PB
0.1520546520066215
Annuals > 3 > ratios > ROE
-1.7057127942184627
Annuals > 3 > ratios > ROA
-0.6411416566450688
Annuals > 3 > ratios > FCF
-1359224000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-0.2613778708848423
Annuals > 3 > health Score
25
Valuation > metrics > PE
18.7315
Valuation > metrics > PB
0.09667546194040004
Valuation > final Score
100
Valuation > verdict
45.2% Undervalued
Profitability > metrics > ROE
2.1295587886277154
Profitability > metrics > ROA
1.9945333698642291
Profitability > metrics > Net Margin
0.09835749156740886
Profitability > final Score
25
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.054199185749327
Risk > metrics > Interest Coverage
1.1537947242223805
Risk > final Score
35
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.6715279693525782
Liquidity > metrics > Quick Ratio
1.578650375021324
Liquidity > final Score
92
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
90
Prev Profitabilities > 0
7
Prev Profitabilities > 1
34
Prev Profitabilities > 2
27
Prev Risks > 0
53
Prev Risks > 1
70
Prev Risks > 2
36
Prev Liquidities > 0
90
Prev Liquidities > 1
92
Prev Liquidities > 2
92
Updated At
2026-01-20T22:10:15.935Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-27
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Luye Pharma Group Ltd., together with its subsidiaries, develops, produces, markets, and sells pharmaceutical products in the People's Republic of China, the United States, Europe, and internationally. The company offers Lipusu for ovarian cancer and carcinoma of ovary; CMNa, a chemical sensitizer for cancer radiotherapy; Boyounuo, an injection for the treatment of various types of cancers; and Xuezhikang, a lipid-regulating drug for the treatment of hypercholesterolaemia. It also provides Maitongna for cerebral edema swelling by trauma or surgery, and for venous reflux disorders; Beixi, an acarbose capsule for Type 2 diabetes; and Seroquel, Seroquel XR, Erzofri, Rivastigmine Multi-Day Transdermal Patch, and Rivastigmine. In addition, the company offers Rykindo, an injection for the treatment of schizophrenia; and Lutingnuo, a glutathione injection for toxicity and injuries caused by ionizing radiation. Further, it offers Oukai; Meibirui; Jinyouping; and other products. The company distributes and sells pharmaceutical drugs; research and development of antibody drugs; and manufactures and sells biopharmaceutical products. Luye Pharma Group Ltd. was founded in 1994 and is headquartered in Yantai, the People's Republic of China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Luye Pharma Group Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.